DBI Group announces departure of CEO Anthony Timbrell

SYDNEY, AUSTRALIA: Dalrymple Bay Infrastructure (DBI) announced today that Anthony Timbrell, Managing Director and Chief Executive Officer, will leave the DBI Group following an orderly transition.

Mr Timbrell has been at DBI and predecessor companies for 15 years, serving as CEO for 13 of those years.

Hon Dr David Hamill AM, Chair of DBI, paid tribute to Mr Timbrell’s leadership. “Anthony has provided outstanding leadership during his fifteen years with the company and as DBI’s inaugural Managing Director, he has built a solid platform for growth,” he said.

“In addition to his successful leadership through the IPO in 2020, Anthony has led the company through numerous growth projects and regulatory resets.”

“Under Anthony’s leadership the company achieved the transformative transition to a light-handed regulatory environment, under which DBI secured a material pricing uplift with CPI indexation with all of its customers, while retaining key commercial terms such as 100% take-or-pay contracts, socialisation of charges in the event of customer default or contract expiries and no force majeure,” Dr Hamill continued.

“This has allowed DBI to establish a predictable and growing distribution profile.”

“Anthony has also played a leading role in the development of DBI’s Transition Strategy to guide the company’s response to climate-related risks and opportunities arising as the global economy moves to a low-carbon future,” Dr Hamill added.

“On behalf of the Board, I would like to sincerely thank Anthony for his exceptional contribution to DBI,” Dr Hamill concluded.

Mr Timbrell said: “I am extremely proud of DBI and our team. During my time at DBI we have maintained an excellent safety record, invested over $400 million in non-expansionary capital (NECAP) into the Dalrymple Bay Terminal for the benefit of our customers, and delivered stable, predictable and growing distributions for our shareholders. DBI is well positioned for growth and I am confident in DBI’s future.”

PharmAust Limited appoints Dr Michael Thum as Chief Executive Officer

Leave a Reply

Your email address will not be published. Required fields are marked *